Hyaluronic Acid Market Global Industry Scenario, Size, Share, Trends, Analysis and Forecast, 2019 - 2028

The hyaluronic acid market would reach USD 18.03 billion by 2028; growing at a CAGR of 8.2% from 2021 to 2028.

The hyaluronic acid market is expected to be driven by the use of hyaluronic across the cosmetics industry used in products and injectables, treatment of osteoarthritis, a growing aging population globally, a rise in related diseases, and faster results. Hyaluronic acid acts as a dermal filler, thereby widely used across skincare and cosmetics surgery. This material is used for the treatment of dry eyes, mouth sores, skin aging, and also as dermal filler in cosmetic surgery. North America is the leading region at present as hyaluronic acid is used here in the form of dermal fillers and viscosupplements for the treatment of osteoarthritis; however Asia Pacific would experience the fastest growth during the forecast period.

The hyaluronic acid market is segmented by application and geography. By application, the market is segmented into Dermal Fillers (scar treatment, lip enhancement, wrinkle correction treatment) Osteoarthritis, ophthalmic and vesicoureteral reflux. The osteoarthritis segment is further bifurcated into single injection sub-segment, three injection sub-segment, and five injection sub-segment.

By geography, the global hyaluronic acid market is classified into North America, Europe, Asia Pacific, and the Rest of the World (RoW). The U.S., Canada, and Mexico are the countries that have been further studied and analyzed independently across North America. Germany, the UK, France, Italy, and Spain are separately studied across Europe; whereas China, Japan, India, Australia, South Korea, and Singapore are under the Asia Pacific. The remaining potential regions such as the Middle East, South & Central America, and Africa are covered under the Rest of the World (RoW).

The leading players in the hyaluronic acid market are F. Hoffmann-La Roche Ltd., Seikagaku Corporation, Galderma S.A, Sanofi (Genzyme), Anika Therapeutics Inc., Salix Pharmaceuticals, Zimmer Holdings Inc., Allergan Inc., Ferring Pharmaceuticals, Inc., and Smith & Nephew Plc.

Top-down and bottom-up approaches are used to validate the global market size and market estimates for players, regions segments, and applicationssegments. The market estimations in the report are based on the marketed sale price of the product. The percentage splits, Market Share (%), and breakdowns of the product segments are derived on the basis of weightings assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major players in the market are identified through secondary research and their market revenues are determined through primary and secondary research. Secondary research includes the research of the annual and financial reports of the top Players; whereas, primary research includes extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs, and marketing executives. The percentage splits, Market Share (%), Growth Rate (%), and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources. This data is combined and added with detailed inputs and analysis presented in the report.

The scope of the report covers an in-depth analysis of the market in terms of both qualitative and quantitative analysis across the segments as well as cross-sectional analysis of the segments including the geographies and its countries. The market has been analyzed both from the demand as well as supply-side to come to an accurate scenario. Products across applications and applications across geographies have been mapped to provide you a precise competitive scenario to have a leading edge in the market.

The Highlights of the Report

• The detailed analysis of the Hyaluronic Acid Market with respect to key segments such as Application and Country has been included in the report
• The Report comprises the qualitative and quantitative analysis of the market with market estimation over 2019 – 2028 and CAGR % between 2021 and 2028
• Comprehensive & Complete analysis of market dynamics including growth factors, restraining factors, and opportunities will be provided in the report.
• An exhaustive regional and country-wise analysis of the Hyaluronic Acid Market has been covered in the report
• Profile of the major key players operating in the Hyaluronic Acid Market will be provided, with a detailed study on their key financials, product portfolio, contribution in next 8 years, competitor analysis, raw material sourcing and supply chain assessment, new developments, and business strategies

Scope of Hyaluronic Acid Market

Hyaluronic Acid Market Segmentation by Application (Revenue, US$ Million, 2019 - 2028)

Dermal fillers

Osteoarthritis

• Single injection
• Three injection
• Five injection
• Ophthalmic
• Vesicoureteral reflux

Hyaluronic Acid Market Segmentation by Geography (Revenue, US$ Million, 2019 - 2028)

North America

• U.S
• Canada

Europe

• U.K.
• France
• Italy
• Germany
• Spain

Asia Pacific

• Japan
• China
• India

Rest of the World (RoW)

• South & Central America
• Middle East
• Africa